Netflix (NASDAQ: NFLX) said that the latest season of Stranger Things surpassed a significant milestone, attracting more than 1.1 billion hours of viewership. It's yet more evidence of Netflix's capability to develop programming that consumers desire. This comes as the company grapples with losing subscribers amid rising competition and decreasing consumer demand for in-home entertainment. Read More...
Motley Fool
Why Oramed Pharmaceuticals Stock Rocketed Higher Today
Shares of the clinical-stage biotech Oramed Pharmaceuticals (NASDAQ: ORMP) were up by a staggering 41.6% as of 3:30 p.m. ET on Friday afternoon. To put this surge in volume into the proper context, the average daily volume for Oramed’s stock over the prior 30-day period has been less than 900,000 shares. Over the last 12 months, Oramed’s stock has attracted short sellers in droves, thanks to the global turmoil in financial markets, the drawdown across clinical-stage biotech stocks, geopolitical unrest, and rising interest rates.
Add Comment